| Pro Physical Therapy | |
|
3127 Valley Ave, Winchester, VA 22601-2635 | |
| (540) 667-1800 | |
| (540) 667-3839 |
| Full Name | Pro Physical Therapy |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 3127 Valley Ave, Winchester, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831209139 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Annetta L Haddox |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1487641023 PECOS PAC ID: 5991606139 Enrollment ID: I20040120000288 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Denise Massie |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1386632792 PECOS PAC ID: 4880676147 Enrollment ID: I20040602000443 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Aaron J Hartstein |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1518955921 PECOS PAC ID: 2062494248 Enrollment ID: I20040602000784 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Amanda N Keatts |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073685954 PECOS PAC ID: 8426150137 Enrollment ID: I20070712000246 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Brian A Collins |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1639452923 PECOS PAC ID: 7810169737 Enrollment ID: I20140717002381 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Brad Dinklocker |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1083157614 PECOS PAC ID: 5193098226 Enrollment ID: I20170912000139 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Sarah E Geraghty |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609398668 PECOS PAC ID: 3375809957 Enrollment ID: I20171115000613 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Jacob Manley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1083120349 PECOS PAC ID: 8729349600 Enrollment ID: I20180312000885 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Heather Ann Barlow |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255708418 PECOS PAC ID: 3779857016 Enrollment ID: I20191029001940 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Provider Name | Shane Zuiker |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1912669318 PECOS PAC ID: 1355732330 Enrollment ID: I20211230000427 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pro Physical Therapy 3127 Valley Ave, Winchester, VA 22601-2635 Ph: (540) 667-1800 | Pro Physical Therapy 3127 Valley Ave, Winchester, VA 22601-2635 Ph: (540) 667-1800 |
News Archive
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
In the world, four billion people suffer from water shortages at least one month a year, according to data from the World Economic Forum.
More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 8 days ago
Lauren Navarrete, Physical Therapist Medicare: Medicare Enrolled Practice Location: 20 E Piccadilly St Ste 11, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 | |
Dana Francis, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Lauck Dr, Winchester, VA 22603 Phone: 540-667-7830 Fax: 540-535-2048 | |
Emily Wernecke, DPT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 230 Costello Dr Ste 1, Winchester, VA 22602 Phone: 540-665-4444 Fax: 540-665-4473 | |
Madison Ernstes, Physical Therapist Medicare: Medicare Enrolled Practice Location: 20 E Piccadilly St Ste 11&14, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 | |
Ann Baker, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 E Piccadilly St Ste 11&14, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 | |
Michelle Anne Young, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 401 Campus Blvd, Winchester, VA 22601 Phone: 540-536-3011 Fax: 540-536-3032 | |
Alison Higinbotham, Physical Therapist Medicare: Medicare Enrolled Practice Location: 20 E Piccadilly St Ste 11&14, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 |